Literature DB >> 30413489

Economic consequences of preterm birth: a systematic review of the recent literature (2009-2017).

Stavros Petrou1, Hei Hang Yiu1, Joseph Kwon2.   

Abstract

BACKGROUND: Despite extensive knowledge on the functional, neurodevelopmental, behavioural and educational sequelae of preterm birth, relatively little is known about its economic consequences.
OBJECTIVE: To systematically review evidence around the economic consequences of preterm birth for the health services, for other sectors of the economy, for families and carers, and more broadly for society.
METHODS: Updating previous reviews, systematic searches of Medline, EconLit, Web of Science, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, Embase and Scopus were performed using broad search terms, covering the literature from 1 January 2009 to 28 June 2017. Studies reporting economic consequences, published in the English language and conducted in a developed country were included. Economic consequences are presented in a descriptive manner according to study time horizon, cost category and differential denominators (live births or survivors).
RESULTS: Of 4384 unique articles retrieved, 43 articles met the inclusion criteria. Of these, 27 reported resource use or cost estimates associated with the initial period of hospitalisation, while 26 reported resource use or costs incurred following the initial hospital discharge, 10 of which also reported resource use or costs associated with the initial period of hospitalisation. Only two studies reported resource use or costs incurred throughout the childhood years. Initial hospitalisation costs varied between $576 972 (range $111 152-$576 972) per infant born at 24 weeks' gestation and $930 (range $930-$7114) per infant born at term (US$, 2015 prices). The review also revealed a consistent inverse association between gestational age at birth and economic costs regardless of date of publication, country of publication, underpinning study design, follow-up period, age of assessment or costing approach, and a paucity of evidence on non-healthcare costs. Several categories of economic costs, such as additional costs borne by families as a result of modifications to their everyday activities, are largely overlooked by this body of literature. Moreover, the number and coverage of economic assessments have not increased in comparison with previous review periods.
CONCLUSION: Evidence identified by this review can be used to inform clinical and budgetary service planning and act as data inputs into future economic evaluations of preventive or treatment interventions. Future research should focus particularly on valuing the economic consequences of preterm birth in adulthood. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  costing; health economics; preterm birth

Mesh:

Year:  2018        PMID: 30413489     DOI: 10.1136/archdischild-2018-315778

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

Review 1.  Tools, techniques, and future opportunities for characterizing the mechanobiology of uterine myometrium.

Authors:  Antonina P Maxey; Megan L McCain
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-07

2.  Cost of neonatal intensive care for extremely preterm infants in Canada.

Authors:  Asaph Rolnitsky; Sharon L Unger; David R Urbach; Chaim M Bell
Journal:  Transl Pediatr       Date:  2021-06

Review 3.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

4.  Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Kypros H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  2020-02-03       Impact factor: 10.693

5.  Protocol for implementation of an evidence based parentally administered intervention for preterm infants.

Authors:  Debra Brandon; Karen Kavanaugh; Karen Gralton; Wei Pan; Evan R Myers; Bree Andrews; Michael Msall; Kathleen F Norr; Rosemary White-Traut
Journal:  BMC Pediatr       Date:  2021-03-24       Impact factor: 2.125

6.  Associations of pre-pregnancy impaired fasting glucose and body mass index among pregnant women without pre-existing diabetes with offspring being large for gestational age and preterm birth: a cohort study in China.

Authors:  Jie Tang; Ruoling Chen; Yizhen Yu; Wei Bao; Henning Tiemeier; Amanda Rodney; Xinhong Zhu; Mingzhen Li; Dongming Huang; Qingguo Zhao
Journal:  BMJ Open Diabetes Res Care       Date:  2021-02

7.  The Potential of Metabolomic Analyses as Predictive Biomarkers of Preterm Delivery: A Systematic Review.

Authors:  Emma Ronde; Irwin K M Reiss; Thomas Hankemeier; Tim G De Meij; Nina Frerichs; Sam Schoenmakers
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-06       Impact factor: 5.555

8.  Current Resources for Evidence-Based Practice, May 2020.

Authors:  Marit L Bovbjerg
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2020-04-10

9.  Temporal trends of care practices, morbidity, and mortality of extremely preterm infants over 10-years in South Wales, UK.

Authors:  Lieve Boel; Sujoy Banerjee; Megan Clark; Annabel Greenwood; Alok Sharma; Nitin Goel; Gautam Bagga; Chuen Poon; David Odd; Mallinath Chakraborty
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

10.  Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The magnum study.

Authors:  Tanya Poppe; Benjamin Thompson; James P Boardman; Mark E Bastin; Jane Alsweiler; Gerard Deib; Jane E Harding; Caroline A Crowther
Journal:  EBioMedicine       Date:  2020-08-25       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.